Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron E Miller

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Neurology|February 13, 2026
The 2024 McDonald Criteria for Diagnosis of Multiple Sclerosis: The Rubber Meets the RoadAaron E Miller
Neurodegenerative Disease Management|September 6, 2021
An updated review of teriflunomide's use in multiple sclerosisAaron E Miller
Clinical Therapeutics|September 15, 2015
Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosisAaron E Miller
Continuum (Minneapolis, Minn.)|December 11, 2012
Editor's preface and farewell. Infectious diseases of the nervous systemAaron E Miller
Continuum (Minneapolis, Minn.)|July 20, 2012
Preface. Lifelong learning in neurologyAaron E Miller
Continuum (Minneapolis, Minn.)|July 20, 2012
Editor'S prefaceAaron E Miller
Continuum (Minneapolis, Minn.)|July 24, 2012
Peripheral neuropathyAaron E Miller
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2024
Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?Aaron E Miller
The Mount Sinai Journal of Medicine, New York|March 23, 2011
Multiple sclerosis: where will we be in 2020?Aaron E Miller
Continuum (Minneapolis, Minn.)|June 5, 2016
Switching or Discontinuing Disease-Modifying Therapies for Multiple SclerosisAaron E Miller
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Neurology|February 13, 2026
The 2024 McDonald Criteria for Diagnosis of Multiple Sclerosis: The Rubber Meets the RoadAaron E Miller
Neurodegenerative Disease Management|September 6, 2021
An updated review of teriflunomide's use in multiple sclerosisAaron E Miller
Clinical Therapeutics|September 15, 2015
Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosisAaron E Miller
Continuum (Minneapolis, Minn.)|December 11, 2012
Editor's preface and farewell. Infectious diseases of the nervous systemAaron E Miller
Continuum (Minneapolis, Minn.)|July 20, 2012
Preface. Lifelong learning in neurologyAaron E Miller
Continuum (Minneapolis, Minn.)|July 20, 2012
Editor'S prefaceAaron E Miller
Continuum (Minneapolis, Minn.)|July 24, 2012
Peripheral neuropathyAaron E Miller
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2024
Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?Aaron E Miller
The Mount Sinai Journal of Medicine, New York|March 23, 2011
Multiple sclerosis: where will we be in 2020?Aaron E Miller
Continuum (Minneapolis, Minn.)|June 5, 2016
Switching or Discontinuing Disease-Modifying Therapies for Multiple SclerosisAaron E Miller
Pageof 7